All change at the top for Boston Scientific
This article was originally published in Clinica
Boston Scientific has appointed James Tobin as president and CEO with immediate effect, replacing co-founder and CEO Pete Nicholas, who will remain chairman of the company. Mr Tobin was previously president and CEO of pharmaceutical company Biogen. Shares in Boston Scientific leapt 16% to $38.8 on the news.